| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin Receptor Substrate Proteins | 91 | 2023 | 557 | 7.150 |
Why?
|
| Insulin | 73 | 2023 | 6597 | 4.080 |
Why?
|
| Phosphoproteins | 51 | 2010 | 2448 | 3.100 |
Why?
|
| Insulin Resistance | 51 | 2023 | 3964 | 2.870 |
Why?
|
| Receptor, Insulin | 27 | 2023 | 836 | 2.420 |
Why?
|
| Liver | 29 | 2023 | 7528 | 1.830 |
Why?
|
| Forkhead Transcription Factors | 16 | 2018 | 1616 | 1.720 |
Why?
|
| Signal Transduction | 74 | 2021 | 23447 | 1.450 |
Why?
|
| Serine | 12 | 2019 | 831 | 1.430 |
Why?
|
| Glucose | 24 | 2023 | 4347 | 1.280 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 37 | 2021 | 2872 | 1.220 |
Why?
|
| Islets of Langerhans | 16 | 2019 | 1341 | 1.180 |
Why?
|
| Insulin-Secreting Cells | 11 | 2021 | 901 | 1.120 |
Why?
|
| Homeostasis | 18 | 2023 | 3323 | 1.030 |
Why?
|
| Follistatin | 3 | 2023 | 137 | 0.960 |
Why?
|
| Proto-Oncogene Proteins c-akt | 21 | 2020 | 2457 | 0.850 |
Why?
|
| Longevity | 6 | 2015 | 1065 | 0.840 |
Why?
|
| Mice, Knockout | 51 | 2023 | 14417 | 0.760 |
Why?
|
| Mice | 94 | 2023 | 81539 | 0.640 |
Why?
|
| Phosphorylation | 39 | 2022 | 8321 | 0.630 |
Why?
|
| Animals | 118 | 2023 | 168475 | 0.610 |
Why?
|
| Hyperglycemia | 7 | 2018 | 1376 | 0.610 |
Why?
|
| Cold Temperature | 1 | 2021 | 785 | 0.570 |
Why?
|
| Glucose Intolerance | 9 | 2021 | 575 | 0.550 |
Why?
|
| Ribosomal Protein S6 Kinases | 2 | 2016 | 203 | 0.530 |
Why?
|
| Threonine | 3 | 2014 | 271 | 0.530 |
Why?
|
| Glucagon-Secreting Cells | 2 | 2021 | 42 | 0.520 |
Why?
|
| Adaptation, Physiological | 3 | 2021 | 1301 | 0.510 |
Why?
|
| Food | 3 | 2009 | 774 | 0.500 |
Why?
|
| Mitochondria | 5 | 2014 | 3624 | 0.490 |
Why?
|
| Fibroblast Growth Factors | 1 | 2021 | 867 | 0.490 |
Why?
|
| Diabetes Mellitus, Type 2 | 17 | 2021 | 12149 | 0.470 |
Why?
|
| Tyrosine | 7 | 2022 | 1440 | 0.470 |
Why?
|
| AMP-Activated Protein Kinases | 3 | 2022 | 598 | 0.450 |
Why?
|
| Diabetes Mellitus, Experimental | 6 | 2013 | 1119 | 0.440 |
Why?
|
| Gluconeogenesis | 5 | 2021 | 185 | 0.430 |
Why?
|
| Insulin-Like Growth Factor I | 7 | 2018 | 1935 | 0.430 |
Why?
|
| Hepatocytes | 7 | 2021 | 1233 | 0.390 |
Why?
|
| Mitogen-Activated Protein Kinases | 5 | 2004 | 1246 | 0.370 |
Why?
|
| Receptors, Leptin | 2 | 2012 | 350 | 0.370 |
Why?
|
| Mice, Transgenic | 16 | 2019 | 9542 | 0.360 |
Why?
|
| Lipid Metabolism | 4 | 2022 | 1902 | 0.350 |
Why?
|
| Blood Glucose | 16 | 2023 | 6391 | 0.350 |
Why?
|
| Glucagon | 5 | 2021 | 532 | 0.330 |
Why?
|
| Phosphatidylinositol 3-Kinases | 18 | 2016 | 2865 | 0.320 |
Why?
|
| Cell Transdifferentiation | 1 | 2010 | 186 | 0.320 |
Why?
|
| MAP Kinase Signaling System | 2 | 2015 | 1486 | 0.320 |
Why?
|
| CHO Cells | 5 | 2016 | 1387 | 0.320 |
Why?
|
| Enzyme Activation | 7 | 2013 | 3597 | 0.320 |
Why?
|
| Hyperinsulinism | 7 | 2020 | 400 | 0.310 |
Why?
|
| Muscle, Skeletal | 11 | 2021 | 4948 | 0.310 |
Why?
|
| Hypoglycemic Agents | 7 | 2014 | 3085 | 0.310 |
Why?
|
| Growth | 2 | 2008 | 365 | 0.310 |
Why?
|
| Receptors, Glucocorticoid | 2 | 2021 | 305 | 0.310 |
Why?
|
| Endocrine Glands | 1 | 2008 | 102 | 0.300 |
Why?
|
| Metabolic Diseases | 3 | 2012 | 683 | 0.300 |
Why?
|
| Cricetinae | 5 | 2016 | 2423 | 0.300 |
Why?
|
| Protein Kinase C | 6 | 2013 | 1202 | 0.290 |
Why?
|
| TOR Serine-Threonine Kinases | 8 | 2016 | 2057 | 0.290 |
Why?
|
| Cricetulus | 4 | 2016 | 814 | 0.290 |
Why?
|
| Obesity | 11 | 2023 | 12947 | 0.280 |
Why?
|
| Leptin | 4 | 2012 | 1597 | 0.280 |
Why?
|
| Diabetes Mellitus | 7 | 2007 | 5841 | 0.280 |
Why?
|
| Multiprotein Complexes | 4 | 2018 | 1120 | 0.270 |
Why?
|
| Adaptor Proteins, Signal Transducing | 7 | 2021 | 2898 | 0.270 |
Why?
|
| Drosophila melanogaster | 1 | 2015 | 1712 | 0.260 |
Why?
|
| Gene Deletion | 4 | 2021 | 2665 | 0.250 |
Why?
|
| Trans-Activators | 6 | 2009 | 2856 | 0.250 |
Why?
|
| Central Nervous System | 1 | 2012 | 1336 | 0.250 |
Why?
|
| Diabetes Mellitus, Type 1 | 4 | 2010 | 3415 | 0.250 |
Why?
|
| Enzyme Inhibitors | 8 | 2022 | 3713 | 0.250 |
Why?
|
| Mice, Inbred C57BL | 21 | 2022 | 22174 | 0.250 |
Why?
|
| Body Weight | 7 | 2021 | 4618 | 0.240 |
Why?
|
| Huntington Disease | 1 | 2011 | 1144 | 0.240 |
Why?
|
| Adipocytes | 3 | 2009 | 1194 | 0.230 |
Why?
|
| Photoreceptor Cells | 1 | 2005 | 236 | 0.230 |
Why?
|
| Down-Regulation | 5 | 2022 | 2919 | 0.220 |
Why?
|
| Protein Kinases | 3 | 2006 | 1608 | 0.220 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2008 | 1115 | 0.220 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2018 | 699 | 0.220 |
Why?
|
| Neurons | 4 | 2020 | 9463 | 0.220 |
Why?
|
| Organ Specificity | 3 | 2021 | 1968 | 0.220 |
Why?
|
| Cyclin D1 | 1 | 2005 | 451 | 0.210 |
Why?
|
| Amino Acid Substitution | 3 | 2016 | 1739 | 0.210 |
Why?
|
| Gene Expression Regulation | 9 | 2021 | 11904 | 0.210 |
Why?
|
| Cyclins | 1 | 2005 | 594 | 0.210 |
Why?
|
| Up-Regulation | 4 | 2012 | 4125 | 0.200 |
Why?
|
| Metformin | 2 | 2012 | 906 | 0.200 |
Why?
|
| Pyrazolones | 1 | 2022 | 8 | 0.200 |
Why?
|
| Glycogen Synthase Kinase 3 | 4 | 2010 | 411 | 0.200 |
Why?
|
| Nitrobenzenes | 1 | 2022 | 66 | 0.200 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2018 | 1492 | 0.200 |
Why?
|
| Basal Metabolism | 1 | 2023 | 161 | 0.200 |
Why?
|
| Tumor Suppressor Proteins | 6 | 2016 | 2805 | 0.200 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2004 | 457 | 0.190 |
Why?
|
| Apoptosis | 12 | 2013 | 9490 | 0.190 |
Why?
|
| Eye Proteins | 1 | 2005 | 633 | 0.190 |
Why?
|
| Brain | 7 | 2021 | 27121 | 0.190 |
Why?
|
| Crosses, Genetic | 4 | 2009 | 750 | 0.190 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2022 | 150 | 0.180 |
Why?
|
| Anisomycin | 3 | 2014 | 27 | 0.180 |
Why?
|
| Gene Expression | 7 | 2018 | 7581 | 0.180 |
Why?
|
| Life Expectancy | 1 | 2008 | 1243 | 0.180 |
Why?
|
| Adipose Tissue | 6 | 2021 | 3313 | 0.180 |
Why?
|
| Adipokines | 1 | 2023 | 310 | 0.180 |
Why?
|
| rho-Associated Kinases | 3 | 2018 | 281 | 0.180 |
Why?
|
| Feedback, Physiological | 2 | 2021 | 476 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 3 | 2012 | 4415 | 0.180 |
Why?
|
| Benzoates | 1 | 2022 | 212 | 0.180 |
Why?
|
| Organ Size | 5 | 2010 | 2254 | 0.170 |
Why?
|
| Adipocytes, Brown | 1 | 2021 | 150 | 0.170 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2020 | 114 | 0.170 |
Why?
|
| Cell Differentiation | 4 | 2018 | 11530 | 0.170 |
Why?
|
| Mice, Mutant Strains | 5 | 2011 | 1749 | 0.170 |
Why?
|
| Obesity, Abdominal | 1 | 2023 | 374 | 0.170 |
Why?
|
| Oxidation-Reduction | 2 | 2021 | 2231 | 0.170 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2018 | 1745 | 0.160 |
Why?
|
| Homeodomain Proteins | 3 | 2005 | 2418 | 0.160 |
Why?
|
| Overnutrition | 1 | 2018 | 25 | 0.160 |
Why?
|
| Blotting, Western | 7 | 2014 | 5035 | 0.160 |
Why?
|
| Energy Metabolism | 5 | 2021 | 2882 | 0.150 |
Why?
|
| Rats | 13 | 2016 | 23741 | 0.150 |
Why?
|
| 3T3-L1 Cells | 1 | 2018 | 209 | 0.150 |
Why?
|
| Cell Line | 13 | 2014 | 15601 | 0.140 |
Why?
|
| Ubiquitin | 1 | 2002 | 839 | 0.140 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2016 | 1252 | 0.140 |
Why?
|
| Heme Oxygenase-1 | 2 | 2010 | 366 | 0.140 |
Why?
|
| Gene Knockdown Techniques | 2 | 2020 | 1612 | 0.140 |
Why?
|
| Prediabetic State | 1 | 2023 | 545 | 0.140 |
Why?
|
| Receptor, IGF Type 1 | 5 | 2013 | 380 | 0.140 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2017 | 123 | 0.140 |
Why?
|
| Lipogenesis | 1 | 2018 | 214 | 0.140 |
Why?
|
| Postprandial Period | 1 | 2018 | 315 | 0.140 |
Why?
|
| Tuberous Sclerosis | 1 | 2004 | 1030 | 0.140 |
Why?
|
| Thermogenesis | 1 | 2021 | 475 | 0.140 |
Why?
|
| Cell Dedifferentiation | 1 | 2016 | 122 | 0.130 |
Why?
|
| Adipose Tissue, Brown | 2 | 2021 | 764 | 0.130 |
Why?
|
| Endotoxemia | 1 | 2017 | 196 | 0.130 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2016 | 126 | 0.130 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2018 | 504 | 0.130 |
Why?
|
| Cells, Cultured | 12 | 2016 | 18966 | 0.130 |
Why?
|
| NAD | 2 | 2010 | 614 | 0.130 |
Why?
|
| Disease Models, Animal | 7 | 2021 | 18255 | 0.130 |
Why?
|
| Genes, ras | 1 | 2018 | 654 | 0.120 |
Why?
|
| Adipose Tissue, White | 1 | 2018 | 365 | 0.120 |
Why?
|
| History, 21st Century | 1 | 2021 | 1567 | 0.120 |
Why?
|
| Mice, Obese | 3 | 2023 | 420 | 0.120 |
Why?
|
| Humans | 52 | 2023 | 761596 | 0.120 |
Why?
|
| Transcription Factors | 9 | 2023 | 12130 | 0.120 |
Why?
|
| Immunoprecipitation | 5 | 2011 | 878 | 0.120 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2016 | 484 | 0.120 |
Why?
|
| Thapsigargin | 1 | 2014 | 102 | 0.120 |
Why?
|
| Cell Survival | 4 | 2005 | 5791 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 3 | 2004 | 73 | 0.120 |
Why?
|
| Tunicamycin | 1 | 2014 | 108 | 0.110 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2014 | 103 | 0.110 |
Why?
|
| Neoplasm Metastasis | 1 | 2004 | 4915 | 0.110 |
Why?
|
| Interleukin-4 | 3 | 2002 | 1149 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2013 | 29 | 0.110 |
Why?
|
| Carrier Proteins | 3 | 2004 | 4937 | 0.110 |
Why?
|
| Peptides | 1 | 2005 | 4358 | 0.110 |
Why?
|
| Glucose Tolerance Test | 5 | 2013 | 1178 | 0.110 |
Why?
|
| Cell Division | 5 | 2003 | 4465 | 0.110 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 3 | 2005 | 441 | 0.110 |
Why?
|
| Models, Biological | 5 | 2010 | 9469 | 0.110 |
Why?
|
| History, 20th Century | 1 | 2021 | 2767 | 0.110 |
Why?
|
| Animals, Newborn | 5 | 2007 | 2677 | 0.110 |
Why?
|
| Male | 41 | 2021 | 360846 | 0.110 |
Why?
|
| Somatomedins | 2 | 2003 | 179 | 0.100 |
Why?
|
| tau Proteins | 1 | 2003 | 2095 | 0.100 |
Why?
|
| Thiolester Hydrolases | 1 | 2013 | 90 | 0.100 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2013 | 91 | 0.100 |
Why?
|
| Ventricular Remodeling | 1 | 2020 | 1267 | 0.100 |
Why?
|
| Immunoblotting | 4 | 2017 | 1646 | 0.100 |
Why?
|
| Receptor, trkA | 1 | 2013 | 159 | 0.100 |
Why?
|
| Dietary Fats | 4 | 2010 | 1995 | 0.100 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2013 | 147 | 0.100 |
Why?
|
| Nerve Growth Factor | 1 | 2013 | 158 | 0.100 |
Why?
|
| Proteins | 3 | 2004 | 6032 | 0.100 |
Why?
|
| Urinary Bladder Diseases | 1 | 2012 | 167 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2002 | 2986 | 0.090 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2011 | 77 | 0.090 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2012 | 256 | 0.090 |
Why?
|
| Glycogen Synthase | 3 | 2009 | 62 | 0.090 |
Why?
|
| Kidney Tubules | 1 | 2013 | 449 | 0.090 |
Why?
|
| Membrane Proteins | 5 | 2017 | 7859 | 0.090 |
Why?
|
| Heart | 2 | 2014 | 4404 | 0.090 |
Why?
|
| Cell Proliferation | 6 | 2013 | 10451 | 0.090 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2012 | 115 | 0.090 |
Why?
|
| Cyclic AMP | 2 | 2005 | 1463 | 0.090 |
Why?
|
| Amino Acids | 4 | 2018 | 1718 | 0.090 |
Why?
|
| Liver Glycogen | 1 | 2009 | 35 | 0.090 |
Why?
|
| Angiotensin II | 1 | 2013 | 849 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2009 | 695 | 0.090 |
Why?
|
| Pancreas | 3 | 2005 | 1691 | 0.090 |
Why?
|
| Hippocampus | 2 | 2021 | 3766 | 0.090 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2009 | 38 | 0.090 |
Why?
|
| Long-Term Potentiation | 1 | 2011 | 293 | 0.080 |
Why?
|
| Autophagy | 2 | 2018 | 1327 | 0.080 |
Why?
|
| Endothelial Cells | 2 | 2013 | 3549 | 0.080 |
Why?
|
| Electron Transport | 1 | 2010 | 210 | 0.080 |
Why?
|
| Transfection | 7 | 2010 | 5774 | 0.080 |
Why?
|
| Diabetes Complications | 1 | 2016 | 1315 | 0.080 |
Why?
|
| Clozapine | 1 | 2013 | 504 | 0.080 |
Why?
|
| Sirtuin 1 | 1 | 2010 | 246 | 0.080 |
Why?
|
| Diphtheria Toxin | 1 | 2010 | 253 | 0.080 |
Why?
|
| Endothelium, Vascular | 1 | 2021 | 4431 | 0.080 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2009 | 295 | 0.080 |
Why?
|
| Gene Knock-In Techniques | 1 | 2010 | 421 | 0.080 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2009 | 269 | 0.080 |
Why?
|
| RNA, Messenger | 6 | 2010 | 12794 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 2917 | 0.080 |
Why?
|
| Bariatric Surgery | 1 | 2018 | 992 | 0.080 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2007 | 59 | 0.070 |
Why?
|
| Epidermis | 2 | 2007 | 528 | 0.070 |
Why?
|
| Phosphotyrosine | 4 | 2013 | 456 | 0.070 |
Why?
|
| Cell Death | 2 | 2010 | 1679 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 2 | 2004 | 30 | 0.070 |
Why?
|
| Mutation, Missense | 1 | 2016 | 2571 | 0.070 |
Why?
|
| Amino Acid Sequence | 4 | 2013 | 13446 | 0.070 |
Why?
|
| Mitosis | 2 | 2009 | 1188 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2012 | 4352 | 0.070 |
Why?
|
| Cytoskeletal Proteins | 1 | 2012 | 1342 | 0.070 |
Why?
|
| Cell Hypoxia | 1 | 2009 | 657 | 0.070 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2011 | 895 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2013 | 1974 | 0.070 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2010 | 858 | 0.070 |
Why?
|
| Diabetic Nephropathies | 1 | 2013 | 973 | 0.070 |
Why?
|
| GTPase-Activating Proteins | 2 | 2009 | 471 | 0.060 |
Why?
|
| Lung Neoplasms | 3 | 2018 | 13381 | 0.060 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2006 | 125 | 0.060 |
Why?
|
| Receptors, Glucagon | 1 | 2005 | 90 | 0.060 |
Why?
|
| Molecular Sequence Data | 4 | 2013 | 17635 | 0.060 |
Why?
|
| Venoms | 1 | 2005 | 94 | 0.060 |
Why?
|
| Lactic Acid | 1 | 2010 | 1139 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 7 | 2005 | 4514 | 0.060 |
Why?
|
| Mutation | 7 | 2016 | 30053 | 0.060 |
Why?
|
| Cyclin D2 | 1 | 2005 | 98 | 0.060 |
Why?
|
| Synaptic Transmission | 1 | 2011 | 1173 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 4576 | 0.060 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2009 | 619 | 0.060 |
Why?
|
| Mice, Inbred NOD | 1 | 2009 | 1827 | 0.060 |
Why?
|
| Aging | 3 | 2011 | 8710 | 0.060 |
Why?
|
| Stress, Physiological | 2 | 2009 | 1403 | 0.060 |
Why?
|
| Superoxide Dismutase | 1 | 2007 | 594 | 0.060 |
Why?
|
| Myocytes, Cardiac | 1 | 2013 | 1668 | 0.060 |
Why?
|
| Female | 26 | 2021 | 392705 | 0.060 |
Why?
|
| Guinea Pigs | 1 | 2005 | 1310 | 0.060 |
Why?
|
| Culture Media, Serum-Free | 1 | 2003 | 148 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2005 | 10766 | 0.060 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2004 | 96 | 0.060 |
Why?
|
| Models, Chemical | 1 | 2005 | 611 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2014 | 4001 | 0.050 |
Why?
|
| Bipolar Disorder | 1 | 2020 | 5092 | 0.050 |
Why?
|
| Bromodeoxyuridine | 1 | 2003 | 311 | 0.050 |
Why?
|
| Burns | 2 | 2005 | 1882 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2009 | 1989 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 1741 | 0.050 |
Why?
|
| Integrases | 1 | 2005 | 518 | 0.050 |
Why?
|
| Environmental Pollutants | 1 | 2012 | 1277 | 0.050 |
Why?
|
| Fasting | 1 | 2009 | 1603 | 0.050 |
Why?
|
| Apolipoproteins E | 2 | 2007 | 1443 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2003 | 813 | 0.050 |
Why?
|
| Tunica Intima | 1 | 2005 | 459 | 0.050 |
Why?
|
| Ceruloplasmin | 1 | 2022 | 56 | 0.050 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2009 | 1136 | 0.050 |
Why?
|
| Propidium | 1 | 2002 | 42 | 0.050 |
Why?
|
| Cell Line, Tumor | 7 | 2017 | 16990 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2010 | 2139 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 613 | 0.050 |
Why?
|
| Consensus Sequence | 1 | 2002 | 365 | 0.050 |
Why?
|
| Islets of Langerhans Transplantation | 2 | 2005 | 740 | 0.050 |
Why?
|
| Thiazolidinediones | 1 | 2005 | 461 | 0.050 |
Why?
|
| Alanine | 2 | 2019 | 609 | 0.050 |
Why?
|
| Androstadienes | 1 | 2003 | 348 | 0.050 |
Why?
|
| Schizophrenia | 1 | 2020 | 6937 | 0.050 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2004 | 507 | 0.050 |
Why?
|
| Interleukin-9 | 1 | 2002 | 62 | 0.050 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2002 | 178 | 0.050 |
Why?
|
| Cell Size | 1 | 2003 | 624 | 0.050 |
Why?
|
| Diabetic Angiopathies | 1 | 2007 | 803 | 0.050 |
Why?
|
| Recombinant Proteins | 2 | 2013 | 6534 | 0.050 |
Why?
|
| Heterozygote | 2 | 2009 | 2787 | 0.050 |
Why?
|
| Body Composition | 1 | 2010 | 2426 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2002 | 522 | 0.050 |
Why?
|
| Regeneration | 1 | 2010 | 1512 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2010 | 2557 | 0.050 |
Why?
|
| Rabbits | 1 | 2007 | 4772 | 0.050 |
Why?
|
| Oxygen Consumption | 1 | 2007 | 1866 | 0.050 |
Why?
|
| Respiration | 1 | 2007 | 1656 | 0.050 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 502 | 0.050 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2001 | 460 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 1693 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2011 | 3113 | 0.040 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2002 | 562 | 0.040 |
Why?
|
| Adenocarcinoma | 2 | 2016 | 6345 | 0.040 |
Why?
|
| Random Allocation | 1 | 2004 | 2395 | 0.040 |
Why?
|
| Copper | 1 | 2022 | 369 | 0.040 |
Why?
|
| Binding Sites | 2 | 2013 | 6056 | 0.040 |
Why?
|
| Cell Cycle Proteins | 3 | 2010 | 3449 | 0.040 |
Why?
|
| Hypercholesterolemia | 1 | 2007 | 1141 | 0.040 |
Why?
|
| Sirolimus | 2 | 2004 | 1533 | 0.040 |
Why?
|
| Receptors, Oxytocin | 1 | 2020 | 69 | 0.040 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2002 | 314 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2020 | 174 | 0.040 |
Why?
|
| Body Temperature Regulation | 1 | 2021 | 292 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 5314 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2004 | 1406 | 0.040 |
Why?
|
| Hypothalamus | 1 | 2004 | 999 | 0.040 |
Why?
|
| Cell Count | 1 | 2003 | 1835 | 0.040 |
Why?
|
| DNA | 2 | 2010 | 7213 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 4243 | 0.040 |
Why?
|
| Kinetics | 2 | 2004 | 6374 | 0.040 |
Why?
|
| Time Factors | 6 | 2007 | 39969 | 0.040 |
Why?
|
| Glycogen | 2 | 2014 | 251 | 0.040 |
Why?
|
| Fibroblasts | 2 | 2006 | 4142 | 0.040 |
Why?
|
| Kidney | 3 | 2010 | 7048 | 0.040 |
Why?
|
| Retinal Ganglion Cells | 1 | 2005 | 811 | 0.040 |
Why?
|
| Immunohistochemistry | 3 | 2008 | 11076 | 0.040 |
Why?
|
| Lipids | 3 | 2022 | 3341 | 0.040 |
Why?
|
| Photic Stimulation | 1 | 2005 | 1987 | 0.040 |
Why?
|
| Point Mutation | 1 | 2003 | 1595 | 0.040 |
Why?
|
| Diet | 2 | 2007 | 8075 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2011 | 3492 | 0.040 |
Why?
|
| Codon, Terminator | 1 | 2018 | 124 | 0.040 |
Why?
|
| Myocardium | 1 | 2010 | 4725 | 0.040 |
Why?
|
| Cytokines | 2 | 2003 | 7396 | 0.040 |
Why?
|
| Eating | 1 | 2004 | 1539 | 0.040 |
Why?
|
| Genotype | 3 | 2009 | 12990 | 0.040 |
Why?
|
| Atherosclerosis | 2 | 2018 | 3407 | 0.040 |
Why?
|
| Models, Animal | 1 | 2004 | 2112 | 0.040 |
Why?
|
| Age Factors | 2 | 2005 | 18399 | 0.040 |
Why?
|
| Cardiomegaly | 1 | 2020 | 590 | 0.040 |
Why?
|
| Disease Progression | 2 | 2011 | 13510 | 0.040 |
Why?
|
| Feeding Behavior | 1 | 2009 | 3188 | 0.030 |
Why?
|
| Protein Stability | 1 | 2018 | 578 | 0.030 |
Why?
|
| Cattle | 2 | 2013 | 3849 | 0.030 |
Why?
|
| Glucose Clamp Technique | 2 | 2008 | 263 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2016 | 8181 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2005 | 3430 | 0.030 |
Why?
|
| Granulosa Cells | 1 | 2016 | 115 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2018 | 368 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 5 | 2007 | 5790 | 0.030 |
Why?
|
| Amino Acid Motifs | 2 | 2013 | 931 | 0.030 |
Why?
|
| Overweight | 1 | 2007 | 2417 | 0.030 |
Why?
|
| Cerebellum | 1 | 2003 | 1501 | 0.030 |
Why?
|
| Smoking | 1 | 2012 | 9053 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2007 | 2576 | 0.030 |
Why?
|
| Diabetic Retinopathy | 1 | 2005 | 1274 | 0.030 |
Why?
|
| Receptors, Interleukin | 1 | 2016 | 243 | 0.030 |
Why?
|
| Ovarian Follicle | 1 | 2016 | 244 | 0.030 |
Why?
|
| Adiponectin | 2 | 2014 | 1113 | 0.030 |
Why?
|
| Protein Isoforms | 2 | 2014 | 1699 | 0.030 |
Why?
|
| Protein Binding | 4 | 2013 | 9353 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2022 | 1808 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2013 | 1136 | 0.030 |
Why?
|
| Muscle Contraction | 2 | 2012 | 1201 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 9610 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2009 | 4652 | 0.030 |
Why?
|
| Rats, Zucker | 1 | 2013 | 131 | 0.030 |
Why?
|
| Swimming | 1 | 2014 | 208 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2013 | 66 | 0.030 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2013 | 37 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2013 | 110 | 0.030 |
Why?
|
| Mice, Inbred Strains | 2 | 2007 | 1762 | 0.030 |
Why?
|
| PC12 Cells | 1 | 2013 | 317 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 3733 | 0.030 |
Why?
|
| Muscarinic Agonists | 1 | 2013 | 91 | 0.030 |
Why?
|
| Deoxyglucose | 2 | 2005 | 333 | 0.030 |
Why?
|
| Bone Density | 1 | 2005 | 3551 | 0.030 |
Why?
|
| Base Sequence | 3 | 2013 | 12441 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2005 | 319 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2013 | 465 | 0.030 |
Why?
|
| Heart Failure | 2 | 2013 | 11671 | 0.030 |
Why?
|
| Mitochondria, Heart | 1 | 2013 | 229 | 0.030 |
Why?
|
| Myosin Light Chains | 1 | 2012 | 121 | 0.030 |
Why?
|
| Keratinocytes | 2 | 2007 | 791 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2013 | 817 | 0.020 |
Why?
|
| Smad4 Protein | 1 | 2013 | 191 | 0.020 |
Why?
|
| Glucokinase | 1 | 2012 | 102 | 0.020 |
Why?
|
| Fetal Heart | 1 | 2013 | 281 | 0.020 |
Why?
|
| bcl-X Protein | 2 | 2004 | 410 | 0.020 |
Why?
|
| STAT6 Transcription Factor | 2 | 2002 | 194 | 0.020 |
Why?
|
| Motor Activity | 1 | 2002 | 2715 | 0.020 |
Why?
|
| Oxidative Phosphorylation | 1 | 2013 | 496 | 0.020 |
Why?
|
| Life Style | 1 | 2023 | 3917 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2016 | 1410 | 0.020 |
Why?
|
| Retroviridae | 2 | 2003 | 850 | 0.020 |
Why?
|
| Adenoviridae | 2 | 2005 | 1085 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2011 | 664 | 0.020 |
Why?
|
| Pyruvic Acid | 1 | 2010 | 204 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2017 | 2206 | 0.020 |
Why?
|
| Portal Vein | 1 | 2012 | 431 | 0.020 |
Why?
|
| Survival Rate | 1 | 2003 | 12723 | 0.020 |
Why?
|
| Biological Transport | 2 | 2005 | 2091 | 0.020 |
Why?
|
| Protein Engineering | 1 | 2013 | 549 | 0.020 |
Why?
|
| Triglycerides | 2 | 2008 | 2461 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2011 | 927 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2002 | 4758 | 0.020 |
Why?
|
| DNA, Neoplasm | 2 | 2004 | 1745 | 0.020 |
Why?
|
| Swine | 1 | 2018 | 5915 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2013 | 1171 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2011 | 705 | 0.020 |
Why?
|
| Epithelium | 1 | 2013 | 1603 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 2 | 2008 | 3792 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2010 | 855 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 1334 | 0.020 |
Why?
|
| Nicotine | 1 | 2012 | 680 | 0.020 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2013 | 829 | 0.020 |
Why?
|
| Italy | 1 | 2009 | 842 | 0.020 |
Why?
|
| Dogs | 1 | 2012 | 3839 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 1756 | 0.020 |
Why?
|
| Neoplasms | 2 | 2008 | 22173 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2013 | 1509 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2014 | 1263 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 2012 | 1152 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2007 | 659 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 3617 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2003 | 5368 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 6484 | 0.020 |
Why?
|
| DNA Primers | 1 | 2009 | 2820 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2005 | 149 | 0.020 |
Why?
|
| Thymidine | 1 | 2005 | 299 | 0.020 |
Why?
|
| Cell Nucleus | 2 | 2005 | 2910 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2008 | 1900 | 0.010 |
Why?
|
| Membranes | 1 | 2004 | 165 | 0.010 |
Why?
|
| Okadaic Acid | 1 | 2004 | 67 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2002 | 10194 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4281 | 0.010 |
Why?
|
| Inflammation | 1 | 2003 | 10774 | 0.010 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2003 | 40 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2008 | 1791 | 0.010 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2003 | 72 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2008 | 988 | 0.010 |
Why?
|
| Thyroid Neoplasms | 1 | 2016 | 2332 | 0.010 |
Why?
|
| Sp1 Transcription Factor | 1 | 2003 | 140 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2008 | 1990 | 0.010 |
Why?
|
| Hindlimb | 1 | 2005 | 513 | 0.010 |
Why?
|
| Phenotype | 2 | 2016 | 16592 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2001 | 7406 | 0.010 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2002 | 61 | 0.010 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2003 | 201 | 0.010 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2003 | 257 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 2004 | 554 | 0.010 |
Why?
|
| C-Peptide | 1 | 2004 | 440 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2009 | 3606 | 0.010 |
Why?
|
| Electroporation | 1 | 2004 | 255 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2005 | 641 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2008 | 3076 | 0.010 |
Why?
|
| Fetus | 1 | 2009 | 1863 | 0.010 |
Why?
|
| Diglycerides | 1 | 2002 | 177 | 0.010 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2004 | 329 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2005 | 838 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 12690 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2005 | 2561 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2003 | 866 | 0.010 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2002 | 101 | 0.010 |
Why?
|
| Growth Disorders | 1 | 2007 | 655 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2004 | 702 | 0.010 |
Why?
|
| Pregnancy | 3 | 2012 | 29890 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 2811 | 0.010 |
Why?
|
| Middle Aged | 4 | 2021 | 220921 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9420 | 0.010 |
Why?
|
| Breast Neoplasms | 4 | 2016 | 21019 | 0.010 |
Why?
|
| Exocytosis | 1 | 2002 | 320 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2002 | 393 | 0.010 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2002 | 436 | 0.010 |
Why?
|
| Cytosol | 1 | 2004 | 888 | 0.010 |
Why?
|
| Muscles | 1 | 2005 | 1576 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 2005 | 1055 | 0.010 |
Why?
|
| Family Health | 1 | 2005 | 1257 | 0.010 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2003 | 364 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2002 | 1545 | 0.010 |
Why?
|
| Luciferases | 1 | 2002 | 714 | 0.010 |
Why?
|
| DNA, Mitochondrial | 1 | 2005 | 865 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 6075 | 0.010 |
Why?
|
| Hyperlipidemias | 1 | 2005 | 771 | 0.010 |
Why?
|
| Transcription, Genetic | 2 | 2005 | 7593 | 0.010 |
Why?
|
| Homozygote | 1 | 2005 | 1776 | 0.010 |
Why?
|
| Feedback | 1 | 2003 | 791 | 0.010 |
Why?
|
| Transgenes | 1 | 2003 | 1010 | 0.010 |
Why?
|
| Blood Proteins | 1 | 2004 | 1173 | 0.010 |
Why?
|
| Endometrial Neoplasms | 1 | 2008 | 1366 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2003 | 1132 | 0.010 |
Why?
|
| Adiposity | 1 | 2009 | 1879 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2002 | 1848 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2004 | 1206 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2003 | 1687 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2002 | 1529 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2008 | 2425 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 2004 | 1154 | 0.010 |
Why?
|
| Alleles | 1 | 2009 | 6864 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 58984 | 0.010 |
Why?
|
| Temperature | 1 | 2004 | 2226 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2008 | 5439 | 0.010 |
Why?
|
| Aorta | 1 | 2005 | 2041 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2005 | 4021 | 0.010 |
Why?
|
| Plasmids | 1 | 2002 | 2269 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2004 | 3597 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2002 | 1060 | 0.010 |
Why?
|
| Cell Separation | 1 | 2002 | 1720 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 6131 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 2822 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2002 | 2645 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2013 | 22176 | 0.010 |
Why?
|
| Young Adult | 2 | 2013 | 59260 | 0.010 |
Why?
|
| Child | 2 | 2013 | 80158 | 0.010 |
Why?
|
| Adult | 3 | 2016 | 221210 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2002 | 2612 | 0.010 |
Why?
|
| Biopsy | 1 | 2005 | 6766 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2003 | 2645 | 0.010 |
Why?
|
| Adolescent | 2 | 2013 | 88326 | 0.010 |
Why?
|
| Macrophages | 1 | 2007 | 5767 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2002 | 5870 | 0.010 |
Why?
|
| Skin | 1 | 2005 | 4484 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2003 | 5112 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2002 | 3677 | 0.010 |
Why?
|
| Aged | 2 | 2016 | 169310 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2005 | 12953 | 0.000 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2004 | 5672 | 0.000 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2003 | 8554 | 0.000 |
Why?
|
| Prostatic Neoplasms | 1 | 2008 | 11122 | 0.000 |
Why?
|
| Risk Factors | 1 | 2012 | 74213 | 0.000 |
Why?
|